About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.05 (-1.94%)
CRBP NASDAQ Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
$4.130
Change (24hr)
-0.16 USD (3.62%)
Volume
981.01K
Volume (4w avg)
-
Open
$4.28
Day Range
$4.04 - $4.52
Previous Close
$4.29
Last Trade
22 Oct, 8:00 pm GMT+0
Delayed
22 Oct, 8:00 pm GMT+0
CRBP price performance
Delayed
22 Oct, 8:00 pm GMT+0
CRBP Market Signals